Steven Cohen's COLL Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 114,006 shares of Collegium Pharmaceutical, Inc. (COLL) worth $4.13 M, representing 0.00% of the portfolio. First purchased in 2016-Q4, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in COLL, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2021, adding 133,522 shares. Largest reduction occurred in Q2 2021, reducing 133,522 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Collegium Pharmaceutical (COLL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Collegium Pharmaceutical (COLL) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +114,006 | New Buy | 114,006 | $36.20 |
| Q4 2023 | -952 | Sold Out | 0 | $0.00 |
| Q3 2023 | +952 | New Buy | 952 | $22.35 |
| Q2 2023 | -1,795 | Sold Out | 0 | $0.00 |
| Q1 2023 | +1,795 | New Buy | 1,795 | $23.99 |
| Q2 2021 | -133,522 | Sold Out | 0 | $0.00 |
| Q1 2021 | +133,522 | New Buy | 133,522 | $23.70 |
| Q1 2017 | -28,000 | Sold Out | 0 | $0.00 |
| Q4 2016 | +28,000 | New Buy | 28,000 | $15.57 |
Steven Cohen's Collegium Pharmaceutical Investment FAQs
Steven Cohen first purchased Collegium Pharmaceutical, Inc. (COLL) in Q4 2016, acquiring 28,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Collegium Pharmaceutical, Inc. (COLL) for 9 quarters since Q4 2016.
Steven Cohen's largest addition to Collegium Pharmaceutical, Inc. (COLL) was in Q1 2021, adding 133,522 shares worth $3.16 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 114,006 shares of Collegium Pharmaceutical, Inc. (COLL), valued at approximately $4.13 M.
As of the Q2 2026 filing, Collegium Pharmaceutical, Inc. (COLL) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Collegium Pharmaceutical, Inc. (COLL) was 133,522 shares, as reported at the end of Q1 2021.